Special Issue
Targeting of immune system in anti-tumor combined therapies
Submission Deadline: 31 December 2020
Articles: 3
Special Issue Editor
Guest Editor
Francesco Novelli
PhD, Uiversity of Turin
Expertise: 130 publications, 48 grants, Editor of 0
Paola Cappello
PhD, University of Turin
Expertise: 80 publications, 4 grants, Editor of 0
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see


Cancer, Immune System, Therapeutics
Share This Special Issue
Published Papers (3 papers)
Open Access

Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma

Barbara Castella, Chiara Riganti, Massimo Massaia
Frontiers in Bioscience-Landmark Volume 25 Issue 1, pp.69-105
DOI: 10.2741/4795 Published: 01 January 2020
Open Access

Macrophages at the crossroads of anticancer strategies

Nina Cortese, Matteo Donadon, Alessandra Rigamonti, Federica Marchesi
Frontiers in Bioscience-Landmark Volume 24 Issue 7, pp.1271-1283
DOI: 10.2741/4779 Published: 01 June 2019
Open Access

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives

Marta Coscia, Candida Vitale, Marco Cerrano, Enrico Maffini, Luisa Giaccone, Mario Boccadoro, Benedetto Bruno
Frontiers in Bioscience-Landmark Volume 24 Issue 7, pp.1284-1315
DOI: 10.2741/4780 Published: 01 June 2019